Welcome to Mediso

Please select your region:

North America
Europe

Please select your language:

Go

About us

Since 1990

Mediso Medical Imaging Systems with headquarters in Budapest is a dynamic supplier of Nuclear Medicine and modern Hybrid Imaging techniques to the health care and medical research institutions of the world. The company was founded in 1990 by experts of the largest research and manufacturing company of the region which has been engaged of nuclear equipment manufacturing since 1960.

Company in numbers

Founded in

1990

Countries

100+

Offices

6

Get in touch

Employees

300+

Pre-Clinical Products

300+

Clinical Products

1350+

View products

Main activities of the company

  • Researching innovative clinical and pre-clinical imaging technologies
  • Developing leading edge clinical and pre-clinical systems
  • Manufacturing, selling and servicing imaging equipment
  • Providing diagnostic clinical services

Research and development

The business strength and perspective of Mediso is based on its R&D activity. To keep production on the leading edge continuous development of new products is a must. The company's declared aim is to develop competitive Nuclear Medicine and Hybrid Imaging equipment applying the most up-to-date technology. More than 50% of Mediso employees are engaged with R&D. (75% of Mediso employees hold higher academic degrees.)

A number of co-operations have been formed with hospitals, clinics and scientific institutions ensuring that the developed technology is in accordance with the needs of Mediso's clinical partners.

Production

The high quality unique systems designed with top level engineering and elaborated solid solutions are implemented to physical reality by the manufacturing section of Mediso. Carefully selected suppliers of quality parts and specialized high-precision subsystem manufacturers are key factors in the quality of final product integration.

Sales and After-sale Services

The Mediso-affiliated USA, German, Polish, Belgian and English subsidiaries and the wordwide distributor network ensures close contact with our customers and offers quick response for their requests. More than 1550 Mediso cameras are installed in more than 100 countries worldwide.

Diagnostic Clinical Services

Mediso operates two PET-CT and nuclear medicine centres at the University of Debrecen and in Budapest. The strong university and clinical background gives Mediso a first-hand clinical experience and important application feedback.

About us

Since 1990, Mediso is creating new technologies, and molecular imaging systems.

Clinical and pre-clinical solutions for hospitals, clinics and scientific institution

  • 1943

    George Hevesy received Nobel Prize for nuclear tracer theory

  • 1972

    Gamma Works released its first NM imager with digital processing

  • 1990

    Foundation of Mediso

  • 1994

    Introduction of the first Mediso gamma camera

  • 1996

    Release of the first SPECT camera Nucline™ X-Ring-R

  • 1998

    Mediso acquired the NM profile of Gamma Works

  • 2000

    Launch of the Nucline™ SPIRIT DH-V variable angle dual head camera

  • 2002

    Nucline X-ring/4R, 4-head dedicated brain SPECT

  • 2005

    Establishing Mediso Gmbh in Munster, Germany

  • 2006

    Launching the first Mediso preclinical system the nanoSPECT/CT

  • 2007

    Production of the first Mediso clinical SPECT/CT. Mediso takes on NM clinical diagnostic service profile acquiring ScanoMed Ltd.

  • 2008

    Launch of AnyScan® multimodality clinical imaging family

  • 2010

    Launch of nanoScan® PET/CT, world’s first ever sub-mm resolution preclinical PET/CT

  • 2012

    Introduction of the nanoScan® PET/MRI 1T, world’s first ever commercial preclinical PET/MRI

  • 2013

    Establishing Mediso USA in Boston, MA

  • 2014

    MultiScan® LFER 150, world’s first sub-mm resolution portable PET/CT

  • 2015

    AnyScan® TRIO SPECT, introduction of triple SPECT detector family

  • 2016

    Opening of new HQ in Budapest, Hungary

  • 2016

    Introducing the nanoScan® PET/MRI 3T world’s first superconducting preclinical PET/MRI